A proposal floated Tuesday by outgoing President Joe Biden to require Medicare and Medicaid to offer coverage for prescriptions of popular but expensive injectable weight loss drugs had the tentative ...
The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...
Whether millions gain access to breakthrough anti-obesity treatments may depend on Kennedy, Mehmet Oz and other key players ...
North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...
The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GLP-1 RA) ...
On Tuesday night, Trump nominated Dr. Jay Bhattacharya to lead the National Institutes of Health, tapping an opponent of ...
Under Secretary for Health Dr. Shereef Elnahal said Monday the VA needs extra funding to cover the costs of drugs such as ...
A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans.
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...
The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...
It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.